Skip to main content
Top
Published in: Annals of Nuclear Medicine 4/2021

01-04-2021 | Hyperparathyroidism | Original Article

11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis

Authors: Daria Maccora, Carmelo Caldarella, Maria Lucia Calcagni

Published in: Annals of Nuclear Medicine | Issue 4/2021

Login to get access

Abstract

Objective

11C-Methionine PET/CT (C-MET) is a promising method in detecting abnormal parathyroid glands in patients with primary hyperparathyroidism (PHPT). The first aim of the study was to evaluate which is the diagnostic role of C-MET in patients with PHPT and inconclusive pre-operative imaging. Second, we aimed to investigate whether C-MET semi-quantitative parameters may reflect biochemical and histological characteristics of involved glands.

Methods

Patients with PHPT, undergoing C-MET after an inconclusive pre-operative imaging and having a parathyroid surgery, were retrospectively included. C-MET visual and semi-quantitative assessment was performed. Parameters, as SUVmax, SUVpeak, SUVmean, functional lesion volume (FLV) and total lesion activity (TLA), were measured for each detected lesion; SUVmean, FLV and TLA were calculated on 40–90% thresholds of SUVmax to define SUVmean40-90, FLV40-90 and TLA40-90, respectively. Results were correlated with patients’ clinical-laboratory (calcium and PTH values) and histological data (size and weight of excised glands). Mann–Whitney test was used and P value < 0.05 was considered significant.

Results

Thirty-eight patients (36 female, age: 57.69 ± 15.13 years) were included. Pre-operative median calcium and PTH values were 11.1 mg/dl [interquartile range (IQR) 10.6–11.5] and 154.6 pg/ml (IQR 101.8–227.0), respectively. C-MET showed a parathyroid uptake in 30 out of thirty-eight patients (78.9%). Among 42 nodules excised, C-MET correctly detected the side of the neck (right/left) in 30/42 with sensitivity, specificity and accuracy of 79, 75 and 79%, respectively. C-MET correctly identified the exact position (superior/inferior) in 27/42 with sensitivity, specificity and accuracy of 75, 50 and 71%, respectively. SUVpeak, FLV50-70 and TLA40-70 were significantly (P < 0.05) higher in patients with higher PTH results. The histological size resulted significantly (P < 0.05) higher in abnormal glands with higher SUVmax, SUVpeak, FLV40-80 and TLA40-90, the weight was higher in glands with higher SUVpeak, SUVmean40-50, FLV40-80 and TLA40-90.

Conclusions

C-MET showed a good performance in detecting hyperfunctioning parathyroid glands in PHPT patients with inconclusive pre-operative imaging. Semi-quantitative PET-derived parameters closely correlated with PTH as well as with size and weight of the excised gland, thus reflecting some biochemical and histological characteristics of involved glands.
Literature
2.
go back to reference Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959–68.CrossRef Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959–68.CrossRef
3.
go back to reference Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253:585–91.CrossRef Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253:585–91.CrossRef
4.
go back to reference Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg. 2009;33:2256–65.CrossRef Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg. 2009;33:2256–65.CrossRef
5.
go back to reference Bellantone R, Raffaelli M, de Crea C, Traini E, Lombardi CP. Minimally-invasive parathyroid surgery. Acta Otorhinolaryngol Ital. 2011;31:207–15.PubMedPubMedCentral Bellantone R, Raffaelli M, de Crea C, Traini E, Lombardi CP. Minimally-invasive parathyroid surgery. Acta Otorhinolaryngol Ital. 2011;31:207–15.PubMedPubMedCentral
6.
go back to reference Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22:123–31.CrossRef Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22:123–31.CrossRef
7.
go back to reference Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, et al. Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT. Endocr J. 2014;61:225–30.CrossRef Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, et al. Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT. Endocr J. 2014;61:225–30.CrossRef
8.
go back to reference Vulpio C, Bossola M, De Gaetano A, Maresca G, Bruno I, Fadda G, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck. 2010;32:1226–35.CrossRef Vulpio C, Bossola M, De Gaetano A, Maresca G, Bruno I, Fadda G, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck. 2010;32:1226–35.CrossRef
9.
go back to reference Bergenfelz AO, Jansson SK, Wallin GK, Mårtensson HG, Rasmussen L, Eriksson HL, et al. Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2708 patients. Langenbecks Arch Surg. 2009;394:851–60.CrossRef Bergenfelz AO, Jansson SK, Wallin GK, Mårtensson HG, Rasmussen L, Eriksson HL, et al. Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2708 patients. Langenbecks Arch Surg. 2009;394:851–60.CrossRef
10.
go back to reference Hindié E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16.CrossRef Hindié E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16.CrossRef
11.
go back to reference Broos WAM, van der Zant FM, Knol RJJ, Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019;40:96–105.CrossRef Broos WAM, van der Zant FM, Knol RJJ, Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019;40:96–105.CrossRef
12.
go back to reference Kluijfhout WP, Vorselaars WM, van den Berk SA, Vriens MR, Borel Rinkes IH, Valk GD, et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun. 2016;37:1246–52.CrossRef Kluijfhout WP, Vorselaars WM, van den Berk SA, Vriens MR, Borel Rinkes IH, Valk GD, et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun. 2016;37:1246–52.CrossRef
13.
go back to reference Kuzminski SJ, Sosa JA, Hoang JK. Update in parathyroid imaging. Magn Reson Imaging Clin N Am. 2018;26:151–66.CrossRef Kuzminski SJ, Sosa JA, Hoang JK. Update in parathyroid imaging. Magn Reson Imaging Clin N Am. 2018;26:151–66.CrossRef
14.
go back to reference Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46:751–65.CrossRef Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46:751–65.CrossRef
16.
go back to reference Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, et al. C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res. 2010;42:209–14.CrossRef Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, et al. C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res. 2010;42:209–14.CrossRef
17.
go back to reference Lenschow C, Gassmann P, Wenning C, Senninger N, Colombo-Benkmann M. Preoperative 11C-methionine PET/CT enables focused parathyroidectomy in MIBI-SPECT negative parathyroid adenoma. World J Surg. 2015;39:1750–7.CrossRef Lenschow C, Gassmann P, Wenning C, Senninger N, Colombo-Benkmann M. Preoperative 11C-methionine PET/CT enables focused parathyroidectomy in MIBI-SPECT negative parathyroid adenoma. World J Surg. 2015;39:1750–7.CrossRef
18.
go back to reference Hayakawa N, Nakamoto Y, Kurihara K, Yasoda A, Kanamoto N, Miura M, et al. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia. Nucl Med Commun. 2015;36:53–9.CrossRef Hayakawa N, Nakamoto Y, Kurihara K, Yasoda A, Kanamoto N, Miura M, et al. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia. Nucl Med Commun. 2015;36:53–9.CrossRef
19.
go back to reference Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS. Detection and characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C-methionine PET/CT and (99m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging. 2013;47:166–72.CrossRef Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS. Detection and characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C-methionine PET/CT and (99m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging. 2013;47:166–72.CrossRef
20.
go back to reference Yuan L, Liu J, Kan Y, Yang J, Wang X. The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis. Acta Radiol. 2017;58:558–64.CrossRef Yuan L, Liu J, Kan Y, Yang J, Wang X. The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis. Acta Radiol. 2017;58:558–64.CrossRef
21.
go back to reference Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43:78–83.CrossRef Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43:78–83.CrossRef
22.
go back to reference Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, et al. Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg. 2013;257:1124–8.CrossRef Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, et al. Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg. 2013;257:1124–8.CrossRef
23.
go back to reference Noltes ME, Coester AM, van der Horst-Schrivers ANA, Dorgelo B, Jansen L, Noordzij W, et al. Localization of parathyroid adenomas using 11C-methionine PET after prior inconclusive imaging. Langenbecks Arch Surg. 2017;402:1109–17.CrossRef Noltes ME, Coester AM, van der Horst-Schrivers ANA, Dorgelo B, Jansen L, Noordzij W, et al. Localization of parathyroid adenomas using 11C-methionine PET after prior inconclusive imaging. Langenbecks Arch Surg. 2017;402:1109–17.CrossRef
24.
go back to reference Herrmann K, Takei T, Kanegae K, Shiga T, Buck AK, Altomonte J, et al. Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Mol Imaging Biol. 2009;11:356–63.CrossRef Herrmann K, Takei T, Kanegae K, Shiga T, Buck AK, Altomonte J, et al. Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Mol Imaging Biol. 2009;11:356–63.CrossRef
25.
go back to reference Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging. 2004;31:1405–12.CrossRef Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging. 2004;31:1405–12.CrossRef
26.
go back to reference Zaidi H, Alavi A, Naqa IE. Novel quantitative PET techniques for clinical decision support in oncology. Semin Nucl Med. 2018;48:548–64.CrossRef Zaidi H, Alavi A, Naqa IE. Novel quantitative PET techniques for clinical decision support in oncology. Semin Nucl Med. 2018;48:548–64.CrossRef
28.
go back to reference Im HJ, Lee IK, Paeng JC, Lee KE, Cheon GJ, Kang KW, et al. Functional evaluation of parathyroid adenoma using 99mTc-MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity. Nucl Med Commun. 2014;35:649–54.CrossRef Im HJ, Lee IK, Paeng JC, Lee KE, Cheon GJ, Kang KW, et al. Functional evaluation of parathyroid adenoma using 99mTc-MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity. Nucl Med Commun. 2014;35:649–54.CrossRef
29.
go back to reference Listewnik MH, Piwowarska-Bilska H, Kurantowicz M, Ostrowski M, Borowiecki A, Safranow K, et al. Semi-quantitative method for the assessment of focal lesions in parathyroid scintigraphy with relation to histopathology: a prospective study. Nucl Med Rev Cent East Eur. 2017;20:18–24.CrossRef Listewnik MH, Piwowarska-Bilska H, Kurantowicz M, Ostrowski M, Borowiecki A, Safranow K, et al. Semi-quantitative method for the assessment of focal lesions in parathyroid scintigraphy with relation to histopathology: a prospective study. Nucl Med Rev Cent East Eur. 2017;20:18–24.CrossRef
30.
go back to reference Çayir D, Araz M, Yalçindağ A, Çakal E. The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism. Nucl Med Commun. 2018;39:304–11.CrossRef Çayir D, Araz M, Yalçindağ A, Çakal E. The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism. Nucl Med Commun. 2018;39:304–11.CrossRef
31.
go back to reference Robin P, Klein R, Gardner J, Ziebarth B, Bazarjani S, Razavi S, et al. Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity. Nucl Med Commun. 2019;40:469–76.CrossRef Robin P, Klein R, Gardner J, Ziebarth B, Bazarjani S, Razavi S, et al. Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity. Nucl Med Commun. 2019;40:469–76.CrossRef
32.
go back to reference Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, et al. 18F fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology. 2017;284:460–7.CrossRef Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, et al. 18F fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology. 2017;284:460–7.CrossRef
34.
go back to reference Maccora D, Rizzo V, Fortini D, Mariani M, Giraldi L, Giordano A, et al. Parathyroid scintigraphy in primary hyperparathyroidism: comparison between double-phase and subtraction techniques and possible affecting factors. J Endocrinol Invest. 2019;42:889–95.CrossRef Maccora D, Rizzo V, Fortini D, Mariani M, Giraldi L, Giordano A, et al. Parathyroid scintigraphy in primary hyperparathyroidism: comparison between double-phase and subtraction techniques and possible affecting factors. J Endocrinol Invest. 2019;42:889–95.CrossRef
37.
go back to reference Hellman P, Ahlström H, Bergström M, Sundin A, Långström B, Westerberg G, et al. Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery. 1994;116:974–81.PubMed Hellman P, Ahlström H, Bergström M, Sundin A, Långström B, Westerberg G, et al. Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery. 1994;116:974–81.PubMed
38.
go back to reference Tang BN, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, et al. Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging. 2008;3:157–63.CrossRef Tang BN, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, et al. Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging. 2008;3:157–63.CrossRef
39.
go back to reference Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, et al. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med. 2013;54:739–47.CrossRef Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, et al. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med. 2013;54:739–47.CrossRef
40.
go back to reference Oksüz MO, Dittmann H, Wicke C, Müssig K, Bares R, Pfannenberg C, et al. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia. Diagn Interv Radiol. 2011;17:297–307.PubMed Oksüz MO, Dittmann H, Wicke C, Müssig K, Bares R, Pfannenberg C, et al. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia. Diagn Interv Radiol. 2011;17:297–307.PubMed
41.
go back to reference Weber T, Gottstein M, Schwenzer S, Beer A, Luster M. Is C-11 methionine PET/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg. 2017;41:980–5.CrossRef Weber T, Gottstein M, Schwenzer S, Beer A, Luster M. Is C-11 methionine PET/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg. 2017;41:980–5.CrossRef
42.
go back to reference Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS. Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol. 2012;19:2272–8.CrossRef Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS. Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol. 2012;19:2272–8.CrossRef
43.
go back to reference Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, et al. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging. 2006;33:453–9.CrossRef Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, et al. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging. 2006;33:453–9.CrossRef
Metadata
Title
11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis
Authors
Daria Maccora
Carmelo Caldarella
Maria Lucia Calcagni
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
Annals of Nuclear Medicine / Issue 4/2021
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-021-01584-w

Other articles of this Issue 4/2021

Annals of Nuclear Medicine 4/2021 Go to the issue